NovaBone Products LLC (NBP) has released a new form of the synthetic bone graft, NovaBone Putty® (bone graft substitute). "Surgeons now have a synthetic that handles more easily," said Arthur Wotiz, CEO of NovaBone Products. "NovaBone
Bioactive Synthetic Graft is the only bone graft substitute that has
been proven to signal, recruit, proliferate and differentiate
osteoblasts.
The events culminate in the formation of strong bone fast," continued Wotiz. No other synthetic bone graft material performs like NovaBone. NovaBone, a calcium-phosphate silicate, goes through an ionic dissolution process that signals the body to send more precursors to the wound site earlier and forms an apatite surface layer that acts as a framework for osteoblast attachment and new bone formation. This results in an increase in osteoblast function over the first few weeks.
The FDA has approved the term osteostimulation to describe Nova Bone's capability. "I have used NovaBone particulate for several hundred spine fusion cases with excellent results," said Craig Chebuhar, MD, Director of the Pinnacle Spine Center in Marietta, GA. "The putty form utilizes the same technology platform - it is ready to use right out of the package, handles great, and doesn't migrate - making it the easiest to use bone graft substitute on the market. The combination of scientific evidence and user friendliness makes this product an excellent grafting option for my patients both as a stand-alone product or as part of a composite bone graft with allograft or autograft," said Chebuhar
NovaBone is the only synthetic that is osteostimulative, directly increasing the proliferation and activity of osteoblasts, the cells responsible for new bone growth. This results in more extensive early bone formation than seen for other synthetic graft materials when evaluated during in vivo testing.
NovaBone Products, LLC is the manufacturer of NovaBone and is headquartered in Jacksonville, FL with laboratory operations in Alachua, FL, a sales office in Shanghai and distributors worldwide. The company is dedicated to delivering best in class synthetic bone graft substitutes to the surgical community, with unprecedented focus on service and commitment to its user base. NBP is in the process of establishing a distribution network in the USA. The company's focus is to select independent distributors and manufacturers representatives that already have good lines of orthopedic hardware and provide them with a complete line of osteobiologics. "We have been extremely pleased with the eager response we have gotten already from distributors across the country", said Art Wotiz, President of NBP. "It seems clear that we are satisfying an important need in the market place", he added.
